Tetraphase Pharmaceuticals, Inc. (TTPH)

Check out top investors' recommendation for TTPH
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
7.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Tetraphase Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of various antibiotics for the treatment of serious and life-threatening multi-drug resistant infections through its chemistry technology. Its principal products include eravacycline, an intravenous and oral antibiotic that use as a empiric monotherapy has completed the Phase II clinical trials for the treatment of multi-drug resistant Gram-negative infections; and eravacycline oral formulation that is in Phase I clinical trials to treat complicated urinary tract infections in intravenous-to-oral step-down therapy. The company?s products that are under development comprise TP-834; and TP-271 that is in preclinical trials for the treatment of respiratory diseases caused by bacterial biothreat pathogens, as well as engages in the development of Pseudomonas/Gram-negative program. Tetraphase Pharmaceuticals, Inc. was founded in 2006 and is based in Watertown, Massachusetts.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Edward Tenthoff Piper Jaffray Buy   Oct 12, '18     6.00  Oct 12, '19  N/A 
Edward Tenthoff Piper Jaffray Buy   Aug 27, '18     8.00  Aug 27, '19  N/A 
Ed Arce Mcnicoll, Lewis, & Vlak Buy   Aug 06, '18     6.00  Aug 06, '19  N/A 
Stephen Willey Stifel Nicolaus & Company, Inc. Buy   Feb 14, '18     6.00  Feb 14, '19  N/A 
Edward Nash Cowen And Company Buy   Feb 14, '18     10.00  Feb 14, '19  N/A 
Edward Tenthoff Piper Jaffray Buy   Feb 14, '18     8.00  Feb 14, '19  N/A 
Ed Arce Mcnicoll, Lewis, & Vlak Buy   Feb 06, '18     17.00  Feb 06, '19  N/A 
Ed Arce Mcnicoll, Lewis, & Vlak Buy   Nov 06, '17     17.00  Nov 06, '18  N/A 
Stephen Willey Stifel Nicolaus & Company, Inc. Buy   Sep 11, '17     13.00  Sep 11, '18  N/A 
Edward Tenthoff Piper Jaffray Buy   Aug 28, '17     14.00  Aug 28, '18  N/A 
Stephen Willey Stifel Nicolaus & Company, Inc. Buy   Jul 26, '17       Jul 26, '18  N/A 
Ian Somaiya Piper Jaffray Buy   Jul 26, '17     13.00  Jul 26, '18  N/A 
Ed Arce Mcnicoll, Lewis, & Vlak Buy   Jul 11, '17     15.00  Jul 11, '18  N/A 
Edward Nash Cowen And Company Buy   Nov 19, '15   11.41  21.00  Nov 19, '16  -64.94% 
Louise Chen Guggenheim Securities LLC Buy   Sep 09, '15   9.49  20.00  Sep 09, '16  -58.90% 
A M Unaffiliated Buy   Aug 10, '15   44.82  53.00  Nov 10, '15  -74.54% 
Alan Carr Needham & Company Buy   May 07, '15   38.85    May 07, '16  -89.09% 
Jonathan Aschoff Brean Murray, Carret & Co. Buy   Apr 27, '15   37.74    Apr 27, '16  -85.40% 
A M Unaffiliated Buy   Mar 25, '15   34.22  48.00  Mar 25, '16  40.27% 
Jonathan Aschoff Brean Murray, Carret & Co. Buy   Mar 06, '15   37.09    Mar 06, '16  -88.27% 
< previous12